D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.32% |
| 2 | Healthcare | 8.96% |
| 3 | Financials | 7.81% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
3551
DELISTED
Apellis Pharmaceuticals
APLS
| $667K | ﹤0.01% |
12,898
-184,466
| -93% | -$9.78M |
|
3552
Phibro Animal Health
PAHC
$1.48B
| $666K | ﹤0.01% |
49,662
+3,345
| +7% | +$44.9K |
|
3553
Yeti Holdings
YETI
$3.93B
| $666K | ﹤0.01% |
16,118
-24,260
| -60% | -$911K |
|
3554
PUT
RXO
RXO
$3.73B
| $666K | ﹤0.01% |
+38,700
| New | +$686K |
|
3555
CALL
Skyworks Solutions
SWKS
$9.73B
| $665K | ﹤0.01% |
7,300
+1,100
| +18% | +$98.6K |
|
3556
CALL
Ally Financial
ALLY
$13.4B
| $665K | ﹤0.01% |
27,200
+6,400
| +31% | +$170K |
|
|
CNCE
3557
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $665K | ﹤0.01% |
+113,848
| New | +$599K |
|
3558
MBIA
MBI
$278M
| $662K | ﹤0.01% |
+51,523
| New | +$589K |
|
3559
Univest Financial
UVSP
$1.24B
| $661K | ﹤0.01% |
25,304
+2,602
| +11% | +$69.8K |
|
3560
Astec Industries
ASTE
$1.26B
| $661K | ﹤0.01% |
+16,246
| New | +$656K |
|
3561
Anterix
ATEX
$1.78B
| $659K | ﹤0.01% |
20,480
+811
| +4% | +$27.6K |
|
3562
CALL
Welltower
WELL
$175B
| $656K | ﹤0.01% |
10,000
| – | – |
|
|
PFTA
3563
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
| $653K | ﹤0.01% |
65,153
+104
| +0.2% | +$1.03K |
|
3564
CALL
Groupon
GRPN
$1.07B
| $652K | ﹤0.01% |
+76,000
| New | +$588K |
|
|
NKLA
3565
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
| $650K | ﹤0.01% |
+10,027
| New | +$838K |
|
3566
Ichor Holdings
ICHR
$2.37B
| $649K | ﹤0.01% |
+24,212
| New | +$646K |
|
|
LAZR
3567
CALL
DELISTED
Luminar Technologies
LAZR
| $648K | ﹤0.01% |
8,727
| – | – |
|
|
MORF
3568
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $647K | ﹤0.01% |
24,203
-21,453
| -47% | -$586K |
|
3569
PUT
Novavax
NVAX
$1.21B
| $643K | ﹤0.01% |
62,500
-20,000
| -24% | -$353K |
|
3570
N-able
NABL
$818M
| $642K | ﹤0.01% |
62,497
-16,108
| -20% | -$172K |
|
|
HEES
3571
DELISTED
H&E Equipment Services
HEES
| $642K | ﹤0.01% |
14,136
-70,156
| -83% | -$2.72M |
|
3572
State Street SPDR S&P Homebuilders ETF
XHB
$1.69B
| $639K | ﹤0.01% |
10,600
+1,900
| +22% | +$113K |
|
|
KNBE
3573
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $639K | ﹤0.01% |
25,775
-99,115
| -79% | -$2.41M |
|
|
CGAU
3574
Centerra Gold
CGAU
$3.19B
| $637K | ﹤0.01% |
+123,100
| New | +$610K |
|
3575
Sprinklr
CXM
$1.48B
| $637K | ﹤0.01% |
77,922
+48,334
| +163% | +$418K |
|
Similar funds
D.E. Shaw & Co's Q4 2022 Portfolio in Review
As of Q4 2022, D.E. Shaw & Co held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
D.E. Shaw & Co's Q4 2022 filing shows 476 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- D.E. Shaw & Co added most to Tesla in Q4 2022, an estimated $826M increase.
- D.E. Shaw & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- D.E. Shaw & Co fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- D.E. Shaw & Co's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- D.E. Shaw & Co opened 476 new positions and closed 783 in Q4 2022.
- D.E. Shaw & Co's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.